A Nasdaq panel ruled the healthcare IT company wouldn’t be delisted from the exchange as long as it complies with financial reporting requirements by late February.
A Nasdaq panel ruled the healthcare IT company wouldn’t be delisted from the exchange as long as it complies with financial reporting requirements by late February.